We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Colgate's Strategic Efforts and Innovation Bolster Growth?
Read MoreHide Full Article
Key Takeaways
CL is using pricing actions and productivity initiatives to offset tariffs and cost pressures.
Colgate is driving growth through premium innovation, including launches and brand relaunches.
CL is investing in digital, analytics and AI to enhance innovation and optimize marketing execution.
Colgate-Palmolive Company (CL - Free Report) is effectively leveraging its pricing power to support growth and mitigate external cost pressures. The company’s productivity program centers on cost savings and efficiency initiatives designed to strengthen its operational foundation. CL’s pricing strategy includes competitive pricing, value-based tactics and price segmentation to address diverse consumer needs while optimizing value.
Colgate’s strong brand equity continues to remain a major competitive advantage, enabling it to maintain positive pricing momentum and resilient volume performance despite a sluggish global consumption environment and significant inflationary pressures. Management emphasized that the strength of its global brands allowed the company to deliver both pricing and volume growth across most categories and divisions, particularly in emerging markets.
Sustained investments in advertising, omnichannel demand generation, digital capabilities and science-based innovation continue to strengthen consumer trust and brand loyalty, supporting Colgate’s ability to offset rising raw material, logistics and tariff-related costs through pricing and premium product innovation. The company is benefiting from key pricing actions, coupled with its funding-the-growth program and other productivity moves, aimed at driving efficiency and expanding margins.
Colgate continues to prioritize innovation as a key driver of growth across categories, geographies and price tiers. Management highlighted that premium innovation is fueling momentum, with launches such as Colgate Miracle Repair serum, EltaMD UV Skin Recovery, and relaunches of Colgate Total, Sanex, Protex, Suavitel, and Hill’s therapeutic lines. Such initiatives are helping strengthen brand health and expand household penetration by bringing consumer-perceived value at every price point.
Beyond Oral Care, Colgate’s skincare brands, including EltaMD and PCA Skin, remain growth engines, supported by consumer trade-ups to premium offerings. The company is also accelerating investment in digital, data, analytics and AI to sharpen its innovation model and optimize marketing execution. Such efforts are likely to continue driving sustained growth and profitability.
CL’s Price Performance, Valuation and Estimates
Colgate’s shares have 16.6% in the past six months compared with the industry’s 1.4% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, CL trades at a forward price-to-earnings ratio of 23.16X compared with the industry’s average of 18.27X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CL’s 2026 and 2027 EPS indicates year-over-year growth of 3.3% and 6%, respectively. The company’s EPS estimate for 2026 has decreased a penny in the past 30 days but the same for 2027 has risen a penny. Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Chefs' Warehouse current financial-year sales indicates growth of 8.3% from the prior-year level. CHEF delivered a trailing four-quarter earnings surprise of 28.9%, on average.
Nomad Foods Limited (NOMD - Free Report) , which manufactures and distributes frozen foods, currently carries a Zacks Rank #2 (Buy).
The Zacks Consensus Estimate for Nomad Foods’ current financial-year sales is expected to rise 0.5% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 8.6%, on average.
Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED delivered an average earnings surprise of 65.5% in the last reported quarter.
The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates a decline of 26% from the year-ago number.
View the Zacks #1 Rank List
Image: Bigstock
Will Colgate's Strategic Efforts and Innovation Bolster Growth?
Key Takeaways
Colgate-Palmolive Company (CL - Free Report) is effectively leveraging its pricing power to support growth and mitigate external cost pressures. The company’s productivity program centers on cost savings and efficiency initiatives designed to strengthen its operational foundation. CL’s pricing strategy includes competitive pricing, value-based tactics and price segmentation to address diverse consumer needs while optimizing value.
Colgate’s strong brand equity continues to remain a major competitive advantage, enabling it to maintain positive pricing momentum and resilient volume performance despite a sluggish global consumption environment and significant inflationary pressures. Management emphasized that the strength of its global brands allowed the company to deliver both pricing and volume growth across most categories and divisions, particularly in emerging markets.
Sustained investments in advertising, omnichannel demand generation, digital capabilities and science-based innovation continue to strengthen consumer trust and brand loyalty, supporting Colgate’s ability to offset rising raw material, logistics and tariff-related costs through pricing and premium product innovation. The company is benefiting from key pricing actions, coupled with its funding-the-growth program and other productivity moves, aimed at driving efficiency and expanding margins.
Colgate continues to prioritize innovation as a key driver of growth across categories, geographies and price tiers. Management highlighted that premium innovation is fueling momentum, with launches such as Colgate Miracle Repair serum, EltaMD UV Skin Recovery, and relaunches of Colgate Total, Sanex, Protex, Suavitel, and Hill’s therapeutic lines. Such initiatives are helping strengthen brand health and expand household penetration by bringing consumer-perceived value at every price point.
Beyond Oral Care, Colgate’s skincare brands, including EltaMD and PCA Skin, remain growth engines, supported by consumer trade-ups to premium offerings. The company is also accelerating investment in digital, data, analytics and AI to sharpen its innovation model and optimize marketing execution. Such efforts are likely to continue driving sustained growth and profitability.
CL’s Price Performance, Valuation and Estimates
Colgate’s shares have 16.6% in the past six months compared with the industry’s 1.4% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, CL trades at a forward price-to-earnings ratio of 23.16X compared with the industry’s average of 18.27X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CL’s 2026 and 2027 EPS indicates year-over-year growth of 3.3% and 6%, respectively. The company’s EPS estimate for 2026 has decreased a penny in the past 30 days but the same for 2027 has risen a penny.
Image Source: Zacks Investment Research
Colgate currently carries a Zacks Rank #3 (Hold).
Stocks to Consider in the Consumer Staples Space
The Chefs' Warehouse, Inc. (CHEF - Free Report) , which is a distributor of specialty food products in the United States, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Chefs' Warehouse current financial-year sales indicates growth of 8.3% from the prior-year level. CHEF delivered a trailing four-quarter earnings surprise of 28.9%, on average.
Nomad Foods Limited (NOMD - Free Report) , which manufactures and distributes frozen foods, currently carries a Zacks Rank #2 (Buy).
The Zacks Consensus Estimate for Nomad Foods’ current financial-year sales is expected to rise 0.5% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 8.6%, on average.
Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED delivered an average earnings surprise of 65.5% in the last reported quarter.
The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates a decline of 26% from the year-ago number.